Cyproterone acetate - Prostate cancer
You are here : Home > Formulary Search > Cyproterone acetate - Prostate cancer
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Evidence Review
PAD Profile
ChemicalSubstance :
Cyproterone acetate
Indication :
Prostate cancer
Group Name :
Keywords :
Brand Names Include :
Cyprostat
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Cyproterone acetate is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Prostate cancer.
Committee Recommendations (1)
The PCN has updated its recommendation for the prescribing of Cyproterone for the treatment of Prostate Cancer. Cyproterone will be considered BLUE (without an information sheet) on the traffic light system.
The initiating consultant should:
1. Supply at least one month medication AND
2. Communicate appropriate monitoring requirements for the individual patient
The initiating consultant should:
1. Supply at least one month medication AND
2. Communicate appropriate monitoring requirements for the individual patient